Unlocking the future of neurology diagnostics: Philips and Synthetic MR join forces to pioneer AI-driven precision imaging tools.
- Philips and Synthetic MR's collaboration aims to revolutionize neurological disorder diagnosis with advanced quantitative brain imaging tools
- The partnership introduces the Smart Quant Neuro 3D MRI software suite, leveraging AI to analyze brain tissues for conditions like multiple sclerosis and traumatic brain injuries
- This initiative highlights the transformative potential of AI in medical imaging, promising precision diagnostics that could significantly impact patient care and outcomes
Philips and SyntheticMR launch AI-based quantitative brain imaging system
Go to source).
Precision Diagnostics to Detect Neurological Disorders
This partnership endeavors to transform the detection and analysis of conditions such as multiple sclerosis, traumatic brain injuries, and dementia, aiming to usher in a new era of precision diagnostics. Traditionally diagnosed through a combination of medical history assessment, physical examination, and diagnostic tests, these disorders are now poised for a paradigm shift with the advent of the Smart Quant Neuro 3DArtificial Intelligence to Analyze Brain Disorders
This innovative software suite amalgamates three cutting-edge technologies: Philips’ SmartSpeed image-reconstruction technology, the 3D SyntAc clinical application, and SyntheticMR’s SyMRI NEURO 3D quantitative tissue assessment software.Did you know?
AI integration in diagnostic imaging is forecasted to reach $1.2bn by 2027, transforming precision and efficiency in medical diagnoses.
How AI is Transforming the Medical Diagnostic Imaging Market
According to GlobalData, a renowned data and analytics company, the integration of AI into the diagnostic imaging market is forecasted to soar to $1.2bn by 2027, marking a significant shift towards enhancing precision, efficiency, and patient outcomes in medical imaging.The diagnostic imaging market, particularly magnetic resonance imaging systems, which boasted a value of $6.2bn in 2023, is anticipated to burgeon to $9.1bn by 2030, propelled by the growing demand for early disease detection and personalized medicine, which fuels advancements in software, hardware, and consumables within the industry.
Medical Image Analysis More Efficient and Accurate with AI
The potential of AI to augment efficiency and accuracy in image analysis underscores its rapid advancement across diverse medical sectors. By seamlessly integrating AI systems and computer vision, the technology aids radiologists and healthcare professionals in identifying tissue abnormalities in scan images, thereby streamlining workloads and suggesting potential treatment pathways based on patients’ medical histories.Further strides in AI could also fortify molecular imaging research, pivotal for comprehending diseases at the cellular level.
Revolutionizing Diagnostic Imaging Through AI Integration
The collaboration between Philips and Synthetic MR represents a watershed moment in diagnostic imaging, contributing to the sector's increasingly indispensable role in preventive healthcare and early disease detection.As the global populace ages and the incidence of diseases like cancer escalates, the efficacy, precision, and accessibility of diagnoses assume paramount importance. This partnership not only underscores the transformative potential of AI in medical imaging but also lays the groundwork for a new era of diagnostic capabilities poised to profoundly impact patient care and outcomes.
Reference:
- Philips and SyntheticMR launch AI-based quantitative brain imaging system - (https://www.medicaldevice-network.com/analyst-comment/philips-syntheticmr-ai-quantitative-brain-imaging-system/)
Source-Medindia